European PRAC continues review reports of Guillain-Barr é syndrome with Astra Zeneca (Vaxzevria) COVID-19 vaccine, EMA

PRAC continues to analyse data on cases of Guillain-Barr é syndrome following vaccination and has requested the marketing authorisation holder to clarify whether further updates to the product information and the risk management plan are necessary.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news